Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
GlaxoSmithKline Boosts Its Cancer Drug Pipeline
British drug giant GlaxoSmithKline (NYSE: GSK) has entered a new oncology arena with its acquisition of Tesaro Inc. (NASDAQ: TSRO) for approximately $5.1 billion. Tesaro is a commercial-stage biopharmaceutical company whose major marketed product, Zejula (niraparib), an oral poly ADP ribose polymerase (PARP) inhibitor, is currently approved for use in ovarian cancer. Specifically, it is in use in the United States and Europe as a treatment for adulta patients with recurrent ovarian cancer who are in response to platinum-based chemotherapy, regardless of BRCA gene mutation or biomarker status. More tests are under way to assess its use in “all-comers” patient populations, as a... Read More »
Propeller Health Flies to ResMed
And Propeller Health makes three. Three deals in 2018, that is, for ResMed Inc. (NYSE: RMD), which picked up Propeller for $225 million on December 3. ResMed is a global medical device maker with more than 6 million cloud-connected devices for daily remote patient monitoring for conditions like sleep apnea, chronic obstructive pulmonary disease (COPD) and other respiratory conditions. Propeller Health is a digital therapeutics company based in Madison, Wisconsin and backed by Aptar Pharma, Safeguard Scientifics, Social Capital, Hikma, 3M Ventures and SR One. Its products treat COPD patients in Stage 2 and 3 severity levels through connectivity, analytics and companion digital experiences.... Read More »
UPMC’s Curavi Health Acquires TripleCare Telemedicine
Curavi Health, Inc., a portfolio company of UPMC Enterprises, has acquired TripleCare, a telemedicine company in the post-acute and long-term care sectors, mirroring a growing trend in the e-health sector of the healthcare industry. Curavi’s takeover of TripleCare will give Curavi command of nearly 100 facilities across 14 states in the United States. TripleCare’s telemedicine platform offers post-acute care patients the opportunity to get treatment from physicians at home, without having to endure costly visits to the emergency room or hospitalizations. Financial terms of the acquisition were not disclosed. This deal echoes InTouch Health’s April 2018 purchase of REACH Health, whose REACH... Read More »
Aeroflow Healthcare Strikes Third Deal in 2018
Consolidation is happening all over the healthcare market, and one little-noticed area is the oxygen-therapy durable medical equipment providers. Aeroflow Healthcare, a home oxygen provider and leading durable medical equipment provider based in Asheville, North Carolina, announced its third deal of the year on December 4. The company is acquiring Wheelock Home Medical’s continuous positive airway pressure (CPAP) resupply program. The deal gives Aeroflow a foot into the Michigan medical device market. CPAP supplies can deteriorate and leak air, and Aeroflow will be able to resupply those devices to ensure effective treatment. In November, Aeroflow purchased a positive airway pressure... Read More »
Health Care M&A Deals, Week Ending December 7, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Biotechnology Acquirer Target Price Advanced Accelerator Applications S.A. License for FF-10158 N/A Biotage AB PhyNexus, Inc. $11,500,000 eHealth Acquirer Target Price ResMed, Inc. Propeller Health $225,000,000 Curavi Health Inc. TripleCare N/A Tabula Rasa HealthCare DoseMe N/A Enovation... Read More »
How Moved My Turkey? November Deals Drop 26%
Calm down. So deal volume plummetted 26%, to a mere 136 deals compared with October’s 183 (that’s a monthly record, by the way). November is typically a slower month for deal making, what with a four-day Thanksgiving holiday diverting attention away from healthcare transactions. This November’s deal volume bested last year’s results by 24% (110 deals), at least. This is still the fourth quarter, after all, and December 31st is looming on the horizon. We expect to see some late-in-the-month action move the quarter’s goal posts toward higher ground. Last year’s fourth quarter ended with 396 transactions, virtually dead even with Q4:16’s 397 deals. We’ll likely beat those totals in 2018.... Read More »
The Top 10 Healthcare Deals of 2018. So Far
It’s been a busy year for healthcare deal makers, and it’s not over yet. With slightly more than 1,700 deals announced as we went to press, this year’s deal volume has already surpassed 2017’s 1,607 total. Dollar volume is on par with last year’s total of $316.3 billion. At the moment, 2018’s spend stands at $316.9 billion. We will likely see a few more big deals in the remaining weeks of December, just as in December 2017. That was the month that CVS Health (NYSE: CVS) and Aetna (NYSE: AET) announced their $77 billion tie-up, Catholic Health Initiatives and Dignity Health made their mega-merger public, Optum (NYSE: UNH) announced its $4.9 billion acquisition of DaVita Medical Group (NYSE:... Read More »
Health Care M&A Deals, Week Ending November 30, 2018
The Health Care M&A Weekly chart is a selection of transactions announced during the prior week(s). The deals presented here are from our Deal Search Online database, which is updated every business day, in the quarterly report. Visit www.dealsearchonline.com to see how Deal Search Online can help you stay up-to-date on the healthcare market overall, or in a particular sector of interest to your firm. Behavioral Health Care Acquirer Target Price Pharos Capital Group LLC ABA of North Texas N/A Discovery Behavioral Health Ambrosia Treatment Center NJ N/A Biotechnology Acquirer Target Price LGC North America Inc. SeraCare Life Sciences, Inc. N/A BeiGene License to ZW25 and ZW49... Read More »
CVS and Aetna Make It Final
Fifty-one weeks after pharmacy retail giant CVS Health (NYSE: CVS) announced its intent to acquire managed care giant Aetna (NYSE: AET), the deal that shook the healthcare industry closed. And now the fun begins. When first announced on December 3, 2017, the deal had many industry players scratching their heads. What does a pharmacy chain with 9,700 pharmacy locations and 1,100 MinuteClinic walk-in clinics, not to mention a major pharmacy benefits manager (Caremark), need with a health insurance company? The answer, as CVS CEO Larry Merlo explained over and over again, is the desire to bring a new model of health care to the masses, by expanding services offerings at its pharmacies so... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
